FDA panel backs Pfizer’s COVID-19 vaccine for kids

Posted online

A Food and Drug Administration advisory panel voted to back Pfizer’s lose-dose COVID-19 vaccine for children.

Members of the panel said the benefits in preventing COVID-19 among 5- to 11-year-olds outweighs potential risks.

The Centers for Disease Control and Prevention next week is slated to decide whether to recommend the shots.

Read more from The Associated Press.